Sellas Life Sciences Group Inc (SLS)
Operating Income Growth
-54.65%
Quarterly · Period ending:
SLS Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-54.65%period ending
Latest reported-54.65%period ending
SLS Quarterly Operating Income YoY % (-257.96% → -54.65%)
Year-over-year change
High-resolution chart · PNG
SLS operating income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income Growth |
|---|---|
| -54.6486% | |
| -52.5977% | |
| -19.3264% | |
| 3.3565% | |
| 9.815% | |
| 37.1384% | |
| 15.3968% | |
| 21.7071% | |
| 15.7901% | |
| 14.5023% | |
| 13.4343% | |
| -30.9964% | |
| -4.9519% | |
| -67.4981% | |
| -59.5878% | |
| -2.4222% | |
| -93.6447% | |
| -200% | |
| -42.3179% | |
| -55.3206% | |
| -4.359% | |
| 44.7589% | |
| 79.2475% | |
| -7.3614% | |
| -6.1707% | |
| 6.7676% | |
| -218.465% | |
| 30.6711% | |
| 38.1787% | |
| 23.311% | |
| 26.6379% | |
| -40.676% | |
| -14.6965% | |
| -27.1304% | |
| -20.2242% | |
| 1.1976% | |
| 39.0013% | |
| 50.145% | |
| 9.9798% | |
| 49.7163% | |
| 14.1775% | |
| 18.3242% | |
| 30.3637% | |
| 34.2746% | |
| 31.4009% | |
| 7.334% | |
| 7.8381% | |
| -90.5992% | |
| -97.6334% | |
| -79.2316% | |
| -121.4055% | |
| -24.6925% | |
| -40.5244% | |
| -49.9093% | |
| 3.9931% | |
| -60.9316% | |
| -149.4732% | |
| 16.3981% | |
| -57.197% | |
| 7.6365% | |
| 52.0825% | |
| -18.3797% | |
| 30.1059% | |
| 6.6047% | |
| 6.3251% | |
| -6.8329% | |
| -31.2159% | |
| -14.9538% | |
| -16.774% | |
| -53.7412% | |
| -46.973% | |
| -19.8616% | |
| 11.1611% | |
| -92.1388% | |
| -257.9634% |